Today, HIV infections are completely treatable thanks to antiretroviral medication. Only problem is these drugs must be taken on a regular basis for them to remain effective, and for many HIV-positive individuals throughout the world, this simply isn’t possible. A new antiretroviral drug called cabotegravir, however, may solve this widespread problem, since it only requires injection once every three months. HIV, like all viruses, thrives by replicating itself, thus turning our body’s cells into little HIV-making factories.
Antiretrovirals interfere with HIV’s ability to replicate. The drugs are used not only on HIV patients to keep the virus at bay, but also as a preventive measure on individuals who are at an increased chance of catching the virus. There are currently more than 20 approved antiretroviral drugs approved for use in the U.S. and Europe, and once a patient starts an…
